These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6119557)

  • 1. Is recurrence inevitable after gallstone dissolution by bile-acid treatment?
    Ruppin DC; Dowling RH
    Lancet; 1982 Jan; 1(8265):181-5. PubMed ID: 6119557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 3. Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones.
    Sylwestrowicz TA; Shaffer EA
    Gastroenterology; 1988 Sep; 95(3):740-8. PubMed ID: 3396819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
    Fromm H
    Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallstone recurrence after oral bile acid dissolution treatment.
    Borum M; Albert M; Fromm H
    Gastroenterology; 1990 Jun; 98(6):1723-4. PubMed ID: 2338211
    [No Abstract]   [Full Text] [Related]  

  • 7. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
    Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
    Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
    Bateson MC; Hill A; Bouchier IA
    Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gall stone dissolving agents.
    Bouchier IA
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):778-80. PubMed ID: 6402249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo kinetics of radiolucent gallstone dissolution by oral dihydroxy bile acids.
    Senior JR; Johnson MF; DeTurck DM; Bazzoli F; Roda E
    Gastroenterology; 1990 Jul; 99(1):243-51. PubMed ID: 2344929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up.
    O'Donnell LD; Heaton KW
    Gut; 1988 May; 29(5):655-8. PubMed ID: 3396952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical dissolution of gallstones by oral bile acid therapy.
    Hofmann AF
    Am J Surg; 1989 Sep; 158(3):198-204. PubMed ID: 2672842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallstones: current concepts of pathogenesis and medical dissolution.
    Shaffer EA
    Can J Surg; 1980 Nov; 23(6):517-32, 557. PubMed ID: 7004612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
    Roda E; Bazzoli F; Labate AM; Mazzella G; Roda A; Sama C; Festi D; Aldini R; Taroni F; Barbara L
    Hepatology; 1982; 2(6):804-10. PubMed ID: 7141392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallstone disappearance after extracorporeal lithotripsy and oral bile acid dissolution.
    Ponchon T; Barkun AN; Pujol B; Mestas JL; Lambert R
    Gastroenterology; 1989 Aug; 97(2):457-63. PubMed ID: 2744359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.
    Podda M; Zuin M; Battezzati PM; Ghezzi C; de Fazio C; Dioguardi ML
    Gastroenterology; 1989 Jan; 96(1):222-9. PubMed ID: 2642440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R; Stiehl A; Götz R; Walker S; Kommerell B
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.